Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Breast cancer. Clinical practice guidelines in oncology.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC; NCCN Breast Cancer Clinical Practice Guidelines Panel.

J Natl Compr Canc Netw. 2009 Feb;7(2):122-92. Review. No abstract available.

PMID:
19200416
2.

Multidisciplinary care for patients with breast cancer.

Hulvat MC, Hansen NM, Jeruss JS.

Surg Clin North Am. 2009 Feb;89(1):133-76, ix. doi: 10.1016/j.suc.2008.10.002. Review.

PMID:
19186235
3.

National Breast Cancer Audit: overview of invasive breast cancer in New Zealand.

Ooi CW, Campbell ID, Kollias J, de Silva P.

N Z Med J. 2012 Aug 10;125(1359):7-16.

PMID:
22932509
4.

Anti-tumor effects of letrozole.

Miller WR, Anderson TJ, Dixon JM.

Cancer Invest. 2002;20 Suppl 2:15-21. Review.

PMID:
12442345
5.

[Slow progress in therapy of breast carcinoma].

Aumiller J.

MMW Fortschr Med. 2004 Jan 22;146(3-4):4-6, 8, 10. German. No abstract available.

PMID:
15035437
6.

[Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].

Sayer HG, Höffken K.

MMW Fortschr Med. 2003 Jun 12;145(24):40-2. German.

PMID:
12866298
7.

Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer.

Seo JH, Kim YH, Kim JS.

Cancer Chemother Pharmacol. 2009 Jan;63(2):261-6. doi: 10.1007/s00280-008-0735-5. Epub 2008 Mar 26.

PMID:
18365197
8.

[Neoadjuvant antihormonal treatment of women with breast cancer].

Tuxen MK, Kamby C, Nielsen DL.

Ugeskr Laeger. 2007 Sep 10;169(37):3077-81. Review. Danish.

PMID:
17877952
9.

Overview of randomized trials of systemic adjuvant therapy.

Ravdin PM.

Cancer Treat Res. 2000;103:157-81. Review. No abstract available.

PMID:
10948446
10.

Adjuvant endocrine treatment of early breast cancer.

Lønning PE.

Hematol Oncol Clin North Am. 2007 Apr;21(2):223-38. Review.

PMID:
17512446
11.

Management of breast cancer--Part II.

Turner NC, Jones AL.

BMJ. 2008 Jul 11;337:a540. doi: 10.1136/bmj.a540. Review. No abstract available.

12.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
13.

Benefit of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

DeGrendele H.

Clin Breast Cancer. 2003 Dec;4(5):311-2. No abstract available.

PMID:
14715105
14.

Selective oestrogen receptor modulators, aromatase inhibitors and the female breast.

Howell A.

Curr Opin Obstet Gynecol. 2005 Aug;17(4):429-34. Review.

PMID:
15976552
15.

Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.

Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC.

J Natl Compr Canc Netw. 2009 Feb;7(2):115-21.

PMID:
19200415
16.
17.

Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.

Booth CM, Pater JL, Goss PE.

Cancer. 2007 May 1;109(9):1927-8; author reply 1928. No abstract available.

18.

[Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].

Tuxen MK, Nielsen DL, Lindberg H, Kamby C.

Ugeskr Laeger. 2007 Jan 22;169(4):297-9. Review. Danish.

PMID:
17274922
19.

Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?

Van Poznak CH, Hayes DF.

J Natl Cancer Inst. 2006 Sep 20;98(18):1261-3. No abstract available.

PMID:
16985239
20.

Tamoxifen: Dr. Jekyll and Mr. Hyde?

Hayes DF.

J Natl Cancer Inst. 2004 Jun 16;96(12):895-7. No abstract available.

PMID:
15199102

Supplemental Content

Support Center